摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-methyl-3-(1-methylcyclopropyl)-1H-pyrazole

中文名称
——
中文别名
——
英文名称
5-methyl-3-(1-methylcyclopropyl)-1H-pyrazole
英文别名
——
5-methyl-3-(1-methylcyclopropyl)-1H-pyrazole化学式
CAS
——
化学式
C8H12N2
mdl
——
分子量
136.19
InChiKey
YXJQBIHIMWZCHL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    28.7
  • 氢给体数:
    1
  • 氢受体数:
    1

文献信息

  • FUSED RING HETEROARYL COMPOUNDS AND THEIR USE AS TRK INHIBITORS
    申请人:HANDOK INC.
    公开号:US20160168156A1
    公开(公告)日:2016-06-16
    The disclosure provides novel chemical compounds represented by Formula I or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof. The compounds can be used as an inhibitor of Trk and are useful in the treatment of pain, cancer, inflammation, neurodegenerative disease and certain infectious diseases. In some compounds of Formula I, Q is —CH═CR 3 C(O)NR 4 R 5 , —C≡CC(O)NR 4 R 5 , or
    该披露提供了由化学式I或其药用可接受的盐、溶剂化合物、多型体、酯、互变异构体或前药表示的新型化合物。这些化合物可用作Trk的抑制剂,并且在治疗疼痛、癌症、炎症、神经退行性疾病和某些传染病方面是有用的。 在化合物I的某些化合物中,Q为—CH═CR3C(O)NR4R5,—C≡CC(O)NR4R5,或...
  • FUSED PYRIMIDINE COMPOUNDS AND USE THEREOF
    申请人:MEDIVATION TECHNOLOGIES, INC.
    公开号:US20140179668A1
    公开(公告)日:2014-06-26
    Fused pyrimidine compounds as kinase inhibitors, such as multi-kinase inhibitors, are provided. Fused pyrimidine compounds as IGF-IR inhibitors are provided. The compounds may be used in a method of treating cancer. Pharmaceutical compositions containing a fused pyrimidine compound and a pharmaceutically acceptable carrier are also provided, as are kits containing a fused pyrimidine compound or salt thereof and instructions for use, e.g., in a method of treating cancer.
    提供了融合嘧啶化合物作为激酶抑制剂,如多激酶抑制剂。提供了融合嘧啶化合物作为IGF-IR抑制剂。这些化合物可用于治疗癌症的方法。还提供了含有融合嘧啶化合物和药用载体的药物组合物,以及含有融合嘧啶化合物或其盐和使用说明的试剂盒,例如用于治疗癌症的方法。
  • SUBSTITUTED N-HETEROCYCLYL- AND N-HETEROARYL-TETRAHYDROPYRIMIDINONES AND THE SALTS THEREOF, AND THE USE OF SAME AS HERBICIDAL ACTIVE SUBSTANCES
    申请人:Bayer Aktiengesellschaft
    公开号:US20200390100A1
    公开(公告)日:2020-12-17
    The present invention relates to substituted N-heterocyclyl- and N-heteroaryltetrahydropyrimidinones of the general formula (I) or salts thereof, where the radicals in the general formula (I) correspond to the definitions given in the description, and to the use thereof as herbicides, in particular for controlling broad-leaved weeds and/or weed grasses in crops of useful plants and/or as plant growth regulators for influencing the growth of crops of useful plants.
    本发明涉及通式(I)或其盐的取代N-杂环烷基和N-杂芳基四氢嘧啶酮,其中通式(I)中的基团对应于描述中给出的定义,并将其用作除草剂,特别是用于控制作物中的阔叶杂草和/或杂草草,并/或作为植物生长调节剂,以影响作物的生长。
  • US9422267B2
    申请人:——
    公开号:US9422267B2
    公开(公告)日:2016-08-23
  • US9701681B2
    申请人:——
    公开号:US9701681B2
    公开(公告)日:2017-07-11
查看更多